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Anticancer effectIn this work we have performed a comparative study on the effect of antineoplastic ether lipid-edelfosine (ED),
its natural analogs— Platelet Activating Factor (PAF) and its precursor (lyso-PAF), both lacking anticancer prop-
erties, on cholesterol/phosphatidylcholine (Chol/PC) monolayers, serving as model membranes. Since all the
above ether lipids are membrane active, it can be expected that their effect on membranes may differentiate
their biological activity. Our investigations were aimed at studying potential relationship of the effect of ED,
PAF and lyso-PAF on model membranes, differing in condensation. We have modiﬁed molecular packing of
Chol/PC model systems either by increasing the level of sterol in the system or changing the structure of PC,
while keeping the same sterol content. Additionally, we have performed a detailed comparison of the miscibility
of ED, PAF and lyso-PAF with various membrane lipids. The collected data evidenced that all the investigated
ether lipids inﬂuence Chol/PC ﬁlms in the same way; however, in a different magnitude. Moreover, the interac-
tions of ED, PAF and lyso-PAF with model membranes were the strongest at the highest level of sterol in the sys-
tem. A thorough analysis of the obtained results has proved that the effect of the investigated ether lipids on
membranes is not dependent on the condensation of the system, but it is strongly determined by the concentra-
tion of cholesterol. Since ED was found to interact with model membranes stronger than PAF and lyso-PAF, we
have suggested that this fact may contribute to differences in cytotoxicity of these compounds.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Biological membrane acts as a barrier through which various drugs
reach the interior of a cell, and frequently biomembrane itself is a target
for various pharmaceuticals. A good example of this kind of drugs are syn-
thetic antitumor lipids covering twomajor groups of compounds, namely
the alkyl ether phospholipids (known also as alkyl-lysophospholipid —
ALPs) and the alkylphosphocholines (APCs) [1]. These molecules
penetrate into membranes of cancer cells and cause a large diversity of
both biochemical effects (e.g. activation of Fas-death receptors, increase
of caspase activity, co-clustering of signaling molecules and rafts, inhibi-
tion of the synthesis of phosphatidylcholines [2–5]) and disturbances in
membrane organization (e.g. decrease in the stored curvature elastic en-
ergy, displacement of proteins from rafts or inhibition of the activity of
membrane-associatedprotein,membranedepolarization anddisordering
in membrane channels [6–8]). A consequence of this action is apoptosis,
and ﬁnally cell death.
A representative of ALPs drugs is edelfosine (ED) — a single chain
synthetic phospholipid of well documented antineoplastic activity to-
wards various cell lines of leukemia [5,9,10], breast [11] or lung [12]
cancer. It is highly important that edelfosine acts as an apoptosis-
promoter very selectively. First of all, this drug induces apoptosis in48 12 634 05 15.
i).
ights reserved.cancer cells sparing normal cells [1,5]. Secondly, edelfosine is not equal-
ly active on various lines of the same cancer cells [9,12,13]. It can be hy-
pothesized that, regardless the exact mechanism of action of this
compound, such a high selectivity of edelfosine may originate from dif-
ferent ability of drug molecules to incorporate into various cellular
membranes. In other words, since anticancer action of edelfosine re-
quires its incorporation into the cell, the composition and properties
may regulate sensitivity of a cell toward the action of this drug.
As regards molecular structure of ED, it is closely related to naturally
occurring family of ether lipids termed Platelet Activating Factor (1-O-
alkyl-2-acetyl-sn-glycero-3-phosphocholine, PAF) as well as to its
deacetylated precursor — lyso-PAF. PAF is a well known from its ability
to induce aggregation and degranulation of platelets [14], and activity in
signaling [15] or inﬂammatory processes [16,17]. On the other hand,
lyso-PAF is biologically inactive [18] or acts antagonistically to PAF
[19]. Phospholipid-like structure and amphiphatic nature of PAF causes
that this compound, similarly to ED, may incorporate into membranes
affecting their organization and properties [20–23]. Interestingly, very
similar structure of these three compounds, that is PAF, lyso-PAF
and ED, does not reﬂect in their similar biological activity. Namely,
PAF is not able to induce apoptosis in cancer cells [1], while ED in
contrast to PAF does not cause aggregation of platelets [24,25]. Tak-
ing into account that all these compounds are membrane-active it
would be very interesting to verify if one of the factors differentiat-
ing biological activity of ED, PAF and lyso-PAF is their different effect
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performed for ED to gain insight into the mechanism of anticancer effect
of thismolecule [26,27]. However, studies on the inﬂuence of PAF or lyso-
PAF on membranes are rather scarce and for artiﬁcial membranes they
have been done only in selected binary systems (e.g. cholesterol/PAF,
phosphatidylethanolamine/PAF or lyso-PAF or DPPC/PAF [28,29]). Unfor-
tunately, this is not sufﬁcient to draw coherent conclusions on the origin
of differences in the activity of these compounds.
In this workwe have compared the effect of PAF, lyso-PAF and ED on
cholesterol/phosphatidylcholine (Chol/PC) monolayers. The studied
mixtures differ in the level of cholesterol or in the structure of PC mole-
cule, resulting in different ﬁlm condensation. The incorporation of ether
lipids into these monolayers allowed us to analyze the correlation be-
tween the molecular packing and the effect induced by ED, PAF and
lyso-PAF, as well as to verify if the foregoing correlation is determined
by the level of cholesterol or by molecular packing in model systems.
Additionally, antitumor efﬁcacy of ED towards various leukemic cells
encouraged us to undertake these experiments. Namely, it was found
that normal leukocytes as well as immature human promyeloblastic
leukemia cells (K-562) are insensitive to apoptotic effect of ED, in con-
trast to human promyelocytic leukemia cells (HL-60) [9,13,30]. It was
suggested that these differencesmay be correlatedwith the level of cho-
lesterol in membranes. This thesis is based on the fact that the incorpo-
ration of ED is faster into the cells of lower sterol level and that the
concentration of cholesterol is higher in resistant to ED K-562 cells
than in ED-sensitive HL-60 cells [30,31 and references therein]. Since
one of the key role of cholesterol in membranes is to regulate their
ﬂuidity, the question raises whether the effect of ED depends on the
presence of cholesterol, or it is determined only by the packing of
membrane. This question is additionally justiﬁed, taking into consider-
ation that ED-sensitive and resistant cells differ in the content of other
lipids, which alsomay change membranes ﬂuidity [9,13,32]. The results
presented in this work provide new important information in this
context.
2. Experimental
2.1. Materials
The investigated ether lipids: C18PAF (1-O-octadecyl-2-acetyl-sn-
glycero-3-phosphocholine) and C18lyso-PAF (1-O-octadecyl-sn-glycero-
3-phosphocholine) of high purity (N99%) were purchased from Bachem
AG Switzerland, whereas edelfosine, ED (1-O-octadecyl-2-O-methyl-
rac-glycero-3-phosphocholine), of purity≥99.1%,was providedbyBiafﬁn
GmbH&Co KG, Germany. Double-chained phospholipids: 1,2-distearoyl-
sn-glycero-3-phosphocholine (DSPC) and 1-stearoyl-2-oleoyl-sn-
glycero-3-phosphocholine (SOPC) as well as ganglioside GM3 (Milk,
Bovine-Ammonium Salt) were the products of high purity (≥99%)
purchased from Avanti Polar Lipids, Inc. Cholesterol (Chol) (≥99%)
was supplied by Sigma. Spreading solutions of DSPC, SOPC and
GM3 were prepared in chloroform:methanol 9:1 v/v mixture,
while cholesterol was dissolved in chloroform. The solvents were
purchased from Aldrich (HPLC grade, ≥99.9%). The mixtures were
prepared from the respective stock solutions and deposited onto
water subphase with the Hamilton micro syringe (±2.0 μL). After
spreading the ﬁlms were left for 10 min. before the compression
was initiated (barrier speed of 20 cm2/min).
2.2. Methods
The experiments were performedwith NIMA (UK) Langmuir trough
(total area = 300 cm2) placed on an anti-vibration table. Surface pres-
sure was measured (±0.1 mN/m) using Wilhelmy plate made of ﬁl-
ter paper (ashless Whatman Chr1) connected to an electrobalance.
The subphase temperature (20 °C) was controlled thermostatically
(±0.1 °C) by a circulating water system. For the experiments UltrapureMilli-Q water was used. Brewster angle microscopy experiments were
performed with UltraBAM instrument (Accurion GmbH, Goettingen,
Germany) equipped with a 50 mW laser emitting p-polarized light at a
wavelength of 658 nm, a 10×magniﬁcation objective, polarizer, analyzer
and a CCD camera. The spatial resolution of BAMwas 2 μm.
2.3. Composition of the studied monolayers
As model membranes Chol/DSPC = 1:2, Chol/SOPC = 1:2, Chol/
SOPC = 1:1 and Chol/SOPC = 2:1 ﬁlms, differing in the packing of
molecules, were used. Into these ﬁlms ED, PAF or lyso-PAF in various
mole fractions (0.05; 0.15, 0.3) were incorporated.
To compare the miscibility of the ether lipids with DSPC and SOPC,
the mixtures of the respective phosphatidylcholines with ED, PAF and
lyso-PAFwere investigated.Moreover, to be able to perform the analysis
of the interactions of the studied ether lipids with various membrane
lipids, we have completed the experiments with studies on the proper-
ties of ganglioside GM3/ether lipids ﬁlms.
2.4. Data analysis
For all of the monolayers studied herein the values of the excess area
ofmixing (AExc)were calculated at the surface pressure of π = 30 mN/m
from Eq. (1) [33]:
AExc ¼ A−Aid ð1Þ
where A are the values of the mean area per molecule derived from the
isotherms at a given surface pressure, while Aid are the areas correspond-
ing to ideal mixing. The Aid values for binary monolayers were calculated
according to Eq. (2)
Aid ¼ A1X1 þ A2X2: ð2Þ
Where A1 and A2 are the mean area per molecule for the respective
one componentﬁlms,whileX1 andX2 are themole fractions of the respec-
tive components in binary ﬁlm [33]. In the case of ternary Chol/PC/ether
lipid monolayers the areas for ideal mixing were calculated from Eq. (3):
Aid ¼ AChol=PCXChol=PC þ Aether lipidXether lipid ð3Þ
where AChol/PC denotes themean area permolecule values estimated from
the isotherms for Chol/PCmixtures at a given surface pressure and XChol/PC
is itsmole fraction in Chol/PC/ether lipid ﬁlm. Aether lipid and Xether lipid refer
to one component ether lipid ﬁlms.
The excess free energy ofmixing (ΔGExc) values for binarymonolayers
was calculated according to Eq. (4) [33].
ΔGExc ¼ N
Zπ
0
AExc dπ ¼N
Zπ
0
A−Aid
 
dπ ð4Þ
where Aid values were calculated from Eq. (2).
3. Results
3.1. The effect of ED, PAF and lyso-PAF on cholesterol/PC monolayers
In the ﬁrst step of our studies, the surface pressure-area isotherms
for Chol/PC monolayers differing in the content of ether lipids (5; 15
and 30%) were recorded. In Fig. 1a–c the isotherms collected for Chol/
DSPC/ether lipids ﬁlms are shown, while in Fig. 2a–c the results for
Chol/SOPC/PAF mixtures are presented. The curves recorded for the
remaining systems (Chol/SOPC/ED and Chol/SOPC/lyso-PAF) are shown
in Supplementary materials (Figs. S1 and S2). As it can be seen, the
incorporation of PAF, lyso-PAF or ED into Chol/DSPC mixture shifts the
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Fig. 1. The surface pressure-area isotherms for Chol/DSPC/ether lipid monolayers.
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Fig. 2. The surface pressure-area isotherms for Chol/SOPC/PAFmonolayers, differing in the
proportion of Chol-to-SOPC.
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more liquid-like state of the ﬁlm. At 30% of PAF in Chol/DSPC mixture,
two collapse surface pressure regions appear in the isotherm, suggesting
the occurrence of a phase separation in the system. This kind of phenom-
enonwas not observed for the remainingmixedmonolayers. The effect of
ether lipids on the characteristics of the curve for Chol/SOPC monolayers
is more complicated that the variation in the position and course of the
isotherms, provoked by PAF, lyso-PAF and ED, depend on the kind of
the investigated ether lipid, its concentration aswell as the level of choles-
terol in the system and the surface pressure. In the main body of this
article we present only the compression isotherms registered for mono-
layers of Chol/SOPC with PAF, while the data recorded for mixtures
containing lyso-PAF and ED are gathered in Fig. S1 and S2 in Supplemen-
tary materials.
From the isotherms recorded for the investigated mixed mono-
layers, the values of the mean area per molecule (A) were estimated
and compared with each other. As regards to binary Chol/PC ﬁlms, the
values of the mean area per molecule for the isotherms compressed to
π = 30 mN/mwere the smallest for Chol/DSPC = 1:2 ﬁlm,which indi-
cates that in this mixture themolecules are themost closely packed. For
Chol/SOPC ﬁlms, A values decreasewith the increase of sterol content in
the system. It should be pointed out that even at the highest level ofcholesterol in Chol/SOPC ﬁlm (2:1 proportion), this monolayer is less
condensed (which reﬂects in larger meanmolecular area at a given sur-
face pressure) as compared to Chol/DSPC = 1:2 monolayer.
The AExc (Eq. (1)) values for binary Chol/PC mixtures in the absence
of ether lipidwere found to be negative (data not shown), which proves
miscibility and favorable packing of molecules being a consequence of
their attractive interactions in the system. This is in accordance with
previously published data [34–36]. In the case of ternary monolayers,
the AExc values were calculated in respect to Chol/PC ﬁlm and one com-
ponent ether lipid monolayer (Eqs. (1) and (3)). Such an approach
allowed us to analyze changes in this parameter caused by the respec-
tive ether lipids in comparison to binary Chol/PC ﬁlms.
As it can be noticed in Fig. 3, for all the systems a very similar trend is
observed. Namely, initially (at 5% of the ether lipid) values of AExc slight-
ly increase (except for Chol/SOPC = 2:1 + PAF or ED mixtures), while
with further addition of ether lipid, they systematically decrease and be-
come negative. Moreover, the AExc values are lower for the systems of
higher cholesterol level. Only in the case of Chol/DSPC/ED monolayers,
the AExc values increase with ED concentration. Considering the way
of calculation of AExc the obtained results should be interpreted as fol-
lows. Positive values of AExc indicate that the mean area per molecule
for ternary mixtures is higher than those resulting from the additivity
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densation of Chol/PC monolayer and weakens the interactions between
molecules. On the other hand, the negative values of this parameter
indicate the stabilizing effect of ether lipid on Chol/PC ﬁlm andmore fa-
vorable interactions between molecules than in Chol/PC monolayer.
Moreover, the higher the concentration of cholesterol in model mem-
brane, the more pronounced the above mentioned effect is.
It is also interesting to note that in contrast to the systems containing
ED, the AExc values for Chol/DSPC/PAF and Chol/SOPC = 1:2 + PAF or
lyso-PAF are very similar.
Tomake the comparison of the effect of PAF, lyso-PAF and ED on the
respective model membranes more clearer, the AExc values for all the
studied systems containing 30% of particular ether lipids have been
compiled in Fig. 4.
The ﬁgure presented above shows that the addition of ether lipids
into the investigated Chol/SOPC mixtures decreases AExc values and
this effect is deﬁnitely the strongest in the case of incorporation of ED
molecules into Chol/SOPC systems (the most negative values of AExc).The most pronounced effect of edelfosine among all the studied ether
lipids was found also at its lower proportion in the mixed monolayers.
Comparing the effect of the remaining ether lipids (PAF vs lyso-PAF) it
can be observed that their inﬂuence depends on the level of cholesterol
in the system. Namely, at lower content of Chol more negative values of
AExc are for lyso-PAF-containing ﬁlms, for Chol/SOPC = 1:1 mixture
these values are similar for both ether lipids-containing ﬁlms, and ﬁnal-
ly at 2:1 Chol to SOPC proportion they become more negative for PAF-
containing system. Similar relation between the AExc values for PAF vs
lyso-PAF-containing Chol/SOPC monolayer was found at lower propor-
tion of these ether lipids in the systems. For Chol/DSPC monolayers the
AExc values change from positive for ED-containing mixtures to slightly
negative for lyso-PAF containing monolayers.
To verify potential differences in the effect of the respective ether
lipids on morphology of the monolayers, BAM images for the studied
systems were taken. As regards Chol/DSPC = 1:2 mixtures, the images
recorded after incorporation of a given amount of ED, PAF or lyso-PAF
into the system were similar for all the studied ether lipids. Therefore
in Fig. 5 only the pictures for PAF-containing systems are shown.
Since themorphology of Chol/DSPCmixtures waswidely investigat-
edwith BAM technique the pictures for this system are not presented in
this work. The images published for these mixtures [34] evidenced for
the existence of condensed domains in gaseous phase at largemolecular
areas and low surface pressures. However, at higher pressures, the ﬁlm
was completely homogenous up to the collapse. At 5% of ether lipid con-
tent in the mixture (Fig. 5), the coexistence of ﬂuid and gaseous phase
can be noticed. With ﬁlm compression, the gaseous phase vanishes
whereas condensed domains dispersed in ﬂuid phase are being formed.
With the increase of the surface pressure, these domains join together
and form chain-like structures observed up to the collapse.
The incorporation of a higher amount of ether lipid into the system,
visibly modiﬁes the ﬁlms' texture. Namely, at 30% of ether lipid in the
mixed ﬁlm at large areas per molecules, the domains of condensed
phase are formedwithin a gaseous region. Upon compression, the num-
ber of these domains increases rapidly and at higher surface pressures
they start to merge and cover practically the entire surface. Generally,
BAM images recorded for monolayers of Chol/DSPC/ether lipid prove
that the single-chained compounds do not mix with the model Chol/
DSPC system, namely in the presented photos the inhomogeneity of
the monolayers was observed during the whole compression. This can
be also inferred from the positive values of AExc for mixtures containing
ED and PAF.
In the same ﬁgure (Fig. 5), BAM images for Chol/SOPC/ether lipid
ﬁlms are shown. As it was evidenced previously [34], Chol/SOPC
monolayers visualized with BAM in awide range of surface pressures
(π = 1 ÷ 36 mN/m) are completely homogenous. Similarly to Chol/
DSPC/ether lipid monolayers discussed above, also in the case of
π = 0 mN/m π = 1.5 mN/m π = 10 mN/m π = 30 mN/m
Chol/DSPC(1:2)/PAF (30%)
π = 45 mN/m
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Fig. 5. BAM images taken for Chol/PC(1:2)/PAF monolayers.
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lipids, a very similar trend in evolution of the morphology of monolayers
was noticed in BAM pictures for ED, PAF and lyso-PAF-containing ﬁlms.
Therefore, in Fig. 5 only the images for Chol/SOPC/PAF mixed ﬁlms are
presented, while subtle differences between the studied systems are de-
scribed below.
At 5% content of PAF and lyso-PAF in themixed ﬁlms, the images are
practically identical. At large molecular areas and zero surface pressure,
the coexistence of 2D gas and ﬂuid can be observed.With ﬁlm compres-
sion, the gaseous phase vanishes and large oval domains within ﬂuid
phase can be detected in the images up to the pressure of ca. 1.5 mN/m.
Then, theﬁlms remain homogenous up to ca. 30 mN/m,where small con-
densed domains start to appear. These domains persist up to the collapse
point; however, they are much smaller than those detected at lower sur-
face pressures. In the case of Chol/SOPC (1:2)/ED (5%)mixture, the ﬁlm is
homogenous up to ca. 11 mN/m, however; during further compression
the domains of the condensed phase systematically appear at the
interface.
As regards to mixtures containing 30% of ether lipid, at large molec-
ular areas, the coexistence of ﬂuid and gaseous phase can be observed in
the pictures. With the compression, the gaseous phase vanishes and
ﬂuid phase exists at the interface. Then (at π = 0.05; 0.08 and 1 mN/m
for PAF, ED and lyso-PAF, respectively), very small domains of rather
low degree of condensation, existing within a ﬂuid matrix up to π = 6;
7.5 and 5 mN/m for PAF, ED and lyso-PAF, respectively are clearly visible.
Above these surface pressure regions, themonolayers are homogenous. In
the case of ED-containing system, the ﬁlm remains uniform up to the col-
lapse, while for PAF and lyso-PAF-containing mixtures at π ≈ 35 mN/m
the condensed domains appear. The above discussed morphology of the
mixed ﬁlms containing unsaturated phospholipid (SOPC) conﬁrms the
miscibility of the components. It is worth mentioning that similarconclusions can also be drawn from the analysis of the images regis-
tered for the remaining monolayers of Chol/SOPC/ether lipids (see
Supplementary materials S3, S4, S5).
3.2. Miscibility and interactions of ED, PAF and lyso-PAF with membrane
lipids
To compare the miscibility and interactions of the studied ether
lipids with phosphatidylcholines, we have also investigated the
properties of binary ether lipid/DSPC and ether lipid/SOPC ﬁlms.
Based on the recorded surface pressure-area curves we have calcu-
lated the AExc values at π = 30 mN/m as well as we have taken
BAM images at various stages of ﬁlms compression. The surface
pressure-area curves for PC/ether lipid ﬁlms (Xether lipid = 0.3) are
presented in Supplementary materials (S6), while AExc values for
these systems are shown in Fig. 6.
As regards to the results of SOPC/ether lipid monolayers, both the
negative values of the AExc as well as homogeneity of the ﬁlm observed
in BAM images (data not presented) suggest that ED, PAF and lyso-PAF
mix favorablywith SOPC inmonolayers. Visiblymore negative values of
AExc for SOPC/EDmonolayersmay suggest that this synthetic ether lipid
interactsmore favorablywith SOPC than PAF and lyso-PAF. On the other
hand, the results obtained for DSPC/ether lipid ﬁlms prove that the
mixing of molecules in these systems is unfavorable. The course of the
isotherms (Supplementary materials, S6), that is the presence of two
collapse points within the curves suggests immiscibility of ﬁlms compo-
nents. This conclusion is supported by positive values of AExc obtained
for these mixed ﬁlms as well as BAM images taken for these mixtures.
In Fig. 7 BAM images for DSPC/ED monolayers are shown (similar
pictures were taken for mixtures containing the remaining ether lipids
therefore they are not presented herein). The pictures registered at
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Table 1
The comparison of the miscibility of various lipids with ED, PAF and lyso-PAF in Langmuir
monolayers. The information concern binary ﬁlms of Xether lipid = 0.3 at the surface
pressure π = 30 mN/m.
(+) denotes positive deviations from ideality, (−) denotes negative deviations from
ideality. Please see comments in the text below.
Deviations from ideality/miscibility
PAF lyso-PAF ED
DSPC (+)/phase separation (+)/phase separation (+)/phase separation
SOPC (−)/miscibility (−)/miscibility (−)/miscibility
DSPE (+)/phase separationa (+)/phase separationa (+)/phase separationa
SOPE (+)/miscibilitya (−)/miscibilitya (+)/phase separationa
DOPE (−)/miscibilitya (−)/miscibilitya (−)/miscibilitya
C18:0-SM (+)/phase separationb (+)/phase separationb (+)/phase separationb
Ganglioside
GM3
(−)/miscibility (−)/miscibility (−)/miscibility
Cholesterol (−)/miscibilityc (−)/miscibilityb (−)/miscibilityd
a Data taken from ref. [29].
b Data taken from ref. [42].
c Data taken from ref. [28].
d Data taken from ref. [43].
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high degree of condensation, which initially is small but they increase
in size and number with ﬁlm compression. For all the systems, these
condensed domains in less condensed phase are visible in pictures up
to the surface pressure near the ﬁrst collapse in the respective iso-
therms. Then, the ﬁlms texture changes to be more uniform, however,
the monolayers remain inhomogeneous up to the collapse.
In Table 1 we have compiled the information on the mixing of the
ether lipids with different membrane lipids, i.e. studied herein as
phosphatidylcholines as well as phosphatidylethanolamines — PE,
sphingomyelin — SM and cholesterol in binary Langmuir monolayers.
Apart from the foregoing compounds, important class of membrane
lipids considered as markers of various tumor cells are gangliosides
[37,38]. These molecules are characterized by the presence of sugar
moiety in the head group fragment, thus their structure is markedly
different from SM or PE molecules. Therefore, it would be interesting
to compare the interactions of ether lipids also with a ganglioside. A
good candidate is GM3, which is overexpressed in various edelfosine
sensitive cells, e.g. breast, brain or lung tumor [39–41]. Unfortunately,
the comparative monolayer studies in this ﬁeld have not been
performed for PAF, lyso-PAF and ED. Therefore, to complete our analysis
we carried out additional experiments for mixed ﬁlms composed of
ganglioside GM3 and ether lipids (the isotherms for these systems con-
taining 30% of ED, PAF or lyso-PAF, respectively are shown in Supple-
mentary materials, S6); BAM images evidence that these monolayers
are completely homogenous in the whole range of the surface pressure
therefore they are not shown).
Data compiled in Table 1 evidence similar tendency in the mixing
properties of all the studied ether lipidswith respectivemembrane lipids.
The results collected for ED, PAF and lyso-PAF prove thatmiscibility of the
studied ether lipids with saturated PC, PE as well as synthetic C18:0 SM is
highly unfavorable and phase separation was detected in the respective
systems. On the other hand, as it was evidenced in our experiments all
the studied ether lipids mix and interact favorably with ganglioside
GM3 and cholesterol. The excess free energy of mixing values (ΔGExc)
calculated based on the isotherms presented in S5 for GM3/ether lipidsFig. 7. BAM images for DSPC/ED monolaye(at 30% of ether lipid) is highly negative (ΔGExc = −760; −1100 and
−1451 J/mol for PAF, lyso-PAF and ED). However, comparing the forego-
ing ΔGExc for GM3/ether lipids with those published for cholesterol/ether
lipids ﬁlms (ΔGExc ≈ −3000 J/mol) it is clear that ED, PAF and lysoPAF
interact more favorably with cholesterol as compared to ganglioside.
4. Discussion
Edelfosine, PAF and lyso-PAF were found to be of different – or even
opposite – biological effects on cells. The ability of these ether lipids to
incorporate into membranes may infer that differences in their mem-
brane activitymay be the key factor responsible for their different cellu-
lar activity. A good way to verify this hypothesis is to compare the
inﬂuence of ED, PAF and lyso-PAF on model lipids membranes, which
are highly useful andwidely applied to study the effects exerted by var-
ious biomolecules on membranes [44,45]. Therefore in this work we
have performed the investigations on the effect of these three ether
lipids on mixed cholesterol/phosphatidylcholine monolayers. The con-
densation of these systems was modiﬁed twofold — either by the level
of cholesterol or by the structure of a phospholipid. We have also
performed a detailed comparison of miscibility and interactions of
these compounds with various membrane lipids in binary ﬁlms. All
these experiments were aimed at verifying the potential correlation be-
tweenmolecular packing of model system and the inﬂuence of particu-
lar ether lipids on the monolayer.
The obtained results evidenced very similar trend as regards to the
effect of particular ether lipids on the respective Chol/PC ﬁlm. As it
was found for Chol/SOPC ﬁlms, differing in the level of cholesterol, the
addition of low proportion of ether lipid (5%) destabilizes the systems,
which manifest in higher – as compared to Chol/PC ﬁlm – values of
the excess area of mixing. However, further increase of ether lipid con-
tent in Chol/SOPC monolayer strengthens the interactions between
molecules as compared to those in the respective Chol/SOPC ﬁlm. It
was also found that thermodynamically favorable inﬂuence of all the
studied ether lipids becomes more pronounced with the increase ofrs at 30% of ether lipid in the mixture.
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for all the studied ether lipids allows one to conclude that the strongest
effect on Chol/SOPCﬁlms is inducedby ED. Based only on this part of our
experiments, a general conclusion can be formulated that in the case
where the condensation of the ﬁlmwasmodiﬁed by the level of choles-
terol, the inﬂuence exerted by ether lipids strengthened with sterol
concentration.
On the other hand, the results of experiments, inwhich the condensa-
tion of model membrane was modiﬁed by the structure of PC at constant
level of cholesterol (Chol/DSPC = 1:2 vs Chol/SOPC = 1:2) aswell as the
studies on binary ether lipid/membrane lipid ﬁlms provided additional
insight into the role of monolayers packing in the effect of ether lipids.
The values of the excess area of mixing (AExc) obtained for Chol/DSPC
1:2 and Chol/SOPC 1:2 in the presence of ether lipids are slightly lower
for Chol/SOPC system. Although for PAF and lyso-PAF-containing mix-
tures they are very comparable between those for Chol/SOPC and Chol/
DSPC ﬁlms, for ED-containing monolayer the differences are more pro-
nounced. Since these systems differ only in the structure of phosphatidyl-
choline, slight strongest interactions in the Chol/SOPC/ether lipid ﬁlms
may result frommore favorablemixing of ether lipids with SOPC as com-
pared to DSPC and weaker interactions between cholesterol and SOPC as
compared to DSPC. This part of our experiments indicates that at a given
level of cholesterol the saturation of PCmolecules is notwithout the inﬂu-
ence on the effect of ether lipids on model systems. However, comparing
the results obtained for all the studied systems it seems that the level of
cholesterol more strongly differentiates the effect of ether lipids on
model membranes than the structure of PC molecule.
To verify the relation between the condensation of Chol/PCﬁlms and
the effect of ether lipids, we have analyzed themeanmolecular areas for
Chol/PC monolayers at 30 mN/m. The values of this parameter are the
smallest for DSPC/Chol then for Chol/SOPC = 2:1, 1:1 and the largest
for Chol/SOPC 1:2. Thus, if there is a simple correlation between conden-
sation ofmonolayer and the effect of ether lipids, the trendof changes in
the effect of ED, PAF and lyso-PAF should be reﬂected in our results in
the same order (that is: Chol/DSPC = 1:2, Chol/SOPC = 2:1 and then
the remaining systems). However, the above relationship was not
found. Instead, we observed that the strongest effect induced by these
ether lipids is on the systemof the highest sterol level. Thus, the concen-
tration of sterol seems to be more important from the point of view of
the effect of ether lipids than the monolayer condensation.
The foregoing conclusion is also supported by the results of the stud-
ies on miscibility and interactions of PAF, lyso-PAF and ED on mono-
layers formed by structurally different membrane lipids. As a result, all
these three ether lipids display very similar behavior in the monolayers
with particular lipids. However, a deeper analysis of the foregoing data
provides interesting conclusion of the role of monolayer packing in the
effect of ether lipids. It was found that ED, PAF and lyso-PAF tend to
phase separate with saturated PCs, SM and PEs [28,29]. However, the
presence of monounsaturated chain(s) in the molecules of PC and PE
improves miscibility of ED, PAF and lyso-PAF with these compounds.
Considering only the foregoing facts it could be proposed that both
PAF and its lyso derivative as well as ED pack more favorably in more
ﬂuid ﬁlms, which are formed by phospholipids having their chain(s)
with cis double bond. However, the results obtained for ganglioside
GM3/ether lipids and cholesterol/ether lipidmonolayers contest this in-
terpretation. Both for GM3 and cholesterol-containing ﬁlms highly neg-
ative deviations from ideality were found indicating favorable mixing
and interactions between molecules both at low and high content of
ED, PAF and lyso-PAF in the mixed ﬁlms. Considering GM3/ether lipids
ﬁlms, these deviations are much more negative than those found for
SOPC/ether lipid and DOPE/ether lipid, although the condensation of
GM3 ﬁlm is higher as compared to the mentioned above phospholipids
(A = 53.1, 57.7 and 64.0 Å2/molecule for GM3, SOPC andDOPE, respec-
tively). This fact contradicts a thesis that the effect of ether lipids on
membrane is determined only by the packing of molecules in the
mixed system.The results showing that ether lipids interact favorably not onlywith
lipids possessing unsaturated chains but also with ganglioside and cho-
lesterol could be explained on the basis of some additional consider-
ations regarding structural aspects. It seems like the key parameter
here is the organization of the single-chained phospholipids' molecules
at the air/water interface. As it was proven by us in one of previously
published articles [46], molecules of PAF and lyso-PAF are tilted from
the surface normal and furthermore, they are strongly immersed into
water subphase, meaning that the head-group region of these mole-
cules are exceptionally large. Because of this reason, the incorporation
of such molecules into periodically ordered monolayer of saturated
PCs or SM (typically at π = 30 mN/m only slightly tilted from surface
normal) is unfavorable. The situation is completely different for the
monolayer of GM3, in which molecules with the bulky head-groups
are organized similarly to the investigated single-chained lipids. For ex-
ample, in the case ofmonolayer of ganglioside GM1 small fraction of the
periodically organized phase was observed at the interface at high sur-
face pressure of 45 mN/m [47]. Therefore, in this case, the incorporated
molecules of ether lipid do not disturb the organization of surface ﬁlm.
At this point the question arises: if such a justiﬁcation is correct, how
to explain the favorable interactions of single-chained lipids with cho-
lesterol? First of all, it is well known that cholesterol interacts more fa-
vorable with phospholipids having large head-group (PCs) over those
with smaller ones (e.g. PEs) [48]. Secondly, a rigidmolecule of cholester-
ol possesses a very small polar head (that is single hydroxyl group), an-
choring this lipid into aqueous subphase. Hence, the potential repulsing
interactions of large head regions of ether lipid molecules are signiﬁ-
cantly reduced by the incorporation of sterol molecules localized in
the region of hydrophobic chains.
The obtained data allow us also to refer to the issue on high selectiv-
ity of ED towards various cells. As it wasmentioned in the Introduction,
the cells of higher sterols level (e.g. immature human promyeloblastic
leukemia cells — K-562) are insensitive to apoptotic effect of ED. On
the other hand, the cells of lower sterol level e.g. human promyelocytic
leukemia cells (HL-60) are sensitive to ED [9,13,30]. It was postulated
that these differences are due to a faster incorporation of ED into the
cells of lower sterol level [30,31 and references therein]. Our results
on model Chol/PC membrane evidenced that strong interactions be-
tween ether lipids and cholesterol inﬂuence their effect on membranes.
It is possible that at a higher sterol level in the system these ED/sterol in-
teractions do not change the membrane organization in a degree sufﬁ-
cient to induce cell toxicity. However, at lower cholesterol level any
decrease in the concentration of this lipid in the membrane may lead
to serious membrane disorders e.g. damage of rafts organization and
functioning.
Finally, we have found that natural ether lipids: PAF and lyso-PAF af-
fect model membranes in the same way; however, in a weaker degree
than synthetic ED. Taking into account that anticancer activity of ED is
related to perturbations in membrane organization induced by this
drug, the observed weaker effect of PAF and lyso-PAF onmodel systems
may explain – to some degree – strong differences in antineoplastic ac-
tivity of these compounds (e.g. the lack of apoptotic activity of PAF vs
strong anticancer effect of ED). On the other hand, the results obtained
herein do not allow us to explain strong differences in biological activity
of PAF and lyso-PAF. As it was found, the effect of these two compounds
on the studied model systems does not differ drastically. The subtle dif-
ferences in the results for PAF vs lyso-PAF do not authorized us to draw
conclusion that the differences in the activity of these two compounds
at membrane level may affect their biological properties. On the other
hand, it is possible that the composition of the studied herein model sys-
temswas not sufﬁcient to observe differences in the inﬂuence of PAF and
lyso-PAF onmembrane. This issue requires further analysis from thepoint
of view of the existence of some speciﬁc lipid, which potentially may dif-
ferentiate the membrane activity of PAF and lyso-PAF. It should be also
taken into account that biological activity of the foregoing natural ether
lipids may not be determined by their behavior in membranes.
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The results obtained in our studies show that ED, PAF and lyso-PAF
affectmodel chol/PCmembranes in similarmanner, however, the effect
of ED is stronger than the effect of the remaining ether lipids. This – in
turn – allows one to speculate that differences in the degree of perturba-
tions induced by ED vs PAF (or lyso-PAF) onmodelmembranesmay dif-
ferentiate also cytotoxic properties of these compounds. Although the
foregoing ﬁndings may explain differences in antitumor properties of
ED vs PAF, the obtained data do not clarify strong differences in biolog-
ical activity of PAF vs lyso-PAF. Since the effect of both these compounds
onmodelmembranes studied hereinwas very similar, we can postulate
that there is other speciﬁc lipid, which differentiates the effect of these
compounds on membranes, or – alternatively – the effect of these
ether lipids onmembranes is not the factor determining their biological
activity. However, this issue requires further analysis.
The most important conclusions provided in this paper concern the
role of the packing of molecules in model membrane in the effect in-
duced by the respective ether lipids. The analysis of the data collected
for monolayers of different condensation modiﬁed by the content of
cholesterol or by the saturation of PC molecule, as well as the results
for binary ether lipid/membrane lipid ﬁlms surely indicate that packing
of molecules in the model system is not a deciding factor regulating the
inﬂuence of PAF, lyso-PAF and ED on membrane. However, our results
indicate for a key role of cholesterol in this aspect.
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